SCHEMBL4273

SCHEMBL4273

CCOC(=O)CCc1ccc(-c2ccc(-c3onc(C)c3CC#CO)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.45
CYP4A11 Q02928 1/20 0.45
ALDH1A1 P00352 3/20 0.41
HRH3 Q9Y5N1 1/20 0.41
SYK P43405 4/20 0.39
FFAR4 Q5NUL3 1/20 0.39
CYP4Z1 Q86W10 1/20 0.38
PDE3B Q13370 1/20 0.36
PDE3A Q14432 1/20 0.36
P2RY12 Q9H244 1/20 0.36
PKM P14618 1/20 0.35
MGLL Q99685 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
GLA P06280 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4663 0.80 CYP4F2 (0.51) CYP4F2CYP4A11ALDH1A1HRH3SYK
SCHEMBL7874 0.78 CYP4F2 (0.43) CYP4F2CYP4A11ALDH1A1HRH3FFAR4
SCHEMBL4097 0.78 CYP4F2 (0.49) CYP4F2CYP4A11ALDH1A1HRH3SYK
SCHEMBL6779 0.77 LPAR1 (0.42) CYP4F2CYP4A11ALDH1A1HRH3FFAR4
SCHEMBL18597925 0.77 LPAR1 (0.43) CYP4F2CYP4A11ALDH1A1HRH3FFAR4
SCHEMBL4272 0.77 CYP4F2 (0.45) CYP4F2CYP4A11ALDH1A1HRH3SYK
SCHEMBL7741 0.75 CYP4F2 (0.39) CYP4F2CYP4A11ALDH1A1HRH3FFAR4
SCHEMBL5585 0.72 LPAR1 (0.47) CYP4F2CYP4A11HRH3SYKCYP4Z1
SCHEMBL6778 0.71 ALOX5 (0.42) CYP4F2CYP4A11ALDH1A1HRH3MGLL
SCHEMBL1555 0.71 HTT (0.45) ALDH1A1PKML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483251-A2 POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
WO-2011041462-A2 POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed